Literature DB >> 24553370

Effect of spleen lymphocytes on the splenomegaly in hepatocellular carcinoma-bearing mice.

Jing Jing Fang1, Zhen Yuan Zhu1, Hui Dong1, Guo Qiang Zheng1, An Guo Teng1, An Jun Liu1.   

Abstract

OBJECTIVE: To study the effect of spleen lymphocytes on the splenomegaly by hepatocellular carcinoma-bearing mouse model.
METHODS: Cell counts, cell cycle distribution, the percentage of lymphocytes subsets and the levels of IL-2 were measured, and two-dimensional gel electrophoresis (2-DE) was used to investigate the relationship between spleen lymphocytes and splenomegaly in hepatocellular carcinoma-bearing mice.
RESULTS: Compared with the normal group, the thymus was obviously atrophied and the spleen was significantly enlarged in the tumor-bearing group. Correlation study showed that the number of whole spleen cells was positively correlated with the splenic index. The cell diameter and cell-cycle phase distribution of splenocytes in the tumor-bearing group showed no significant difference compared to the normal group. The percentage of CD3+ T lymphocytes and CD8+ T lymphocytes in spleen and peripheral blood of tumor-bearing mice were substantially higher than that in the normal mice. Meanwhile, the IL-2 level was also higher in the tumor-bearing group than in the normal group. Furthermore, two dysregulated protein, β-actin and S100-A9 were identified in spleen lymphocytes from H22-bearing mice, which were closely related to cellular motility.
CONCLUSION: It is suggested that dysregulated β-actin and S100-A9 can result in recirculating T lymphocytes trapped in the spleen, which may explain the underlying cause of splenomegaly in H22-bearing mice.
Copyright © 2014 The Editorial Board of Biomedical and Environmental Sciences. Published by China CDC. All rights reserved.

Entities:  

Keywords:  Hepatocellular carcinoma; Lymphocytes; S100-A9; Splenomegaly; β-actin

Mesh:

Year:  2014        PMID: 24553370     DOI: 10.3967/bes2014.012

Source DB:  PubMed          Journal:  Biomed Environ Sci        ISSN: 0895-3988            Impact factor:   3.118


  8 in total

1.  Antitumor activity of yulangsan polysacchrides in mice bearing S180 sarcoma tumors.

Authors:  Wen'E Cai; Xiaoyu Chen; Qingdong Pan; Shijun Zhang; Luojiao Tan; Xuyong Sun; Renbin Huang; Aijun Xia
Journal:  Mol Clin Oncol       Date:  2017-08-16

2.  Effects of yak-activated protein on hematopoiesis and related cytokines in radiation-induced injury in mice.

Authors:  Yabin Duan; Xingchen Yao; Junbo Zhu; Yongping Li; Juanling Zhang; Xuejiao Zhou; Yijie Qiao; Meng Yang; Xiangyang Li
Journal:  Exp Ther Med       Date:  2017-10-03       Impact factor: 2.447

3.  Distribution characteristics of cells in splenomegaly due to hepatitis B-related cirrhotic portal hypertension and their clinical importance.

Authors:  Xiaoyu Han; Yunfu Lv; Yejuan Li; Jie Deng; Qingan Qiu; Ning Liu; Shuya Zhao; Caixian Liao
Journal:  J Int Med Res       Date:  2018-05-20       Impact factor: 1.671

4.  Establishment of a mouse model of cancer cachexia with spleen deficiency syndrome and the effects of atractylenolide I.

Authors:  Wan-Li Zhang; Na Li; Qiang Shen; Men Fan; Xiao-Dong Guo; Xiong-Wen Zhang; Zhou Zhang; Xuan Liu
Journal:  Acta Pharmacol Sin       Date:  2019-07-24       Impact factor: 6.150

5.  Investigation into imbalance of Th1/Th2 cells in cirrhotic, hypersplenic rats.

Authors:  Yunfu Lv; Yejuan Li; Ning Liu; Yonghong Dong; Jie Deng
Journal:  J Int Med Res       Date:  2019-12-18       Impact factor: 1.671

6.  Rapamycin-filgrastim combination therapy ameliorates portal hypertension-induced splenomegaly: Role of β actin and S100A9 proteins modulation.

Authors:  Shaimaa A Abdelrahman; Mohammed M Abdelfatah; Akaber T Keshta
Journal:  Iran J Basic Med Sci       Date:  2022-06       Impact factor: 2.532

7.  Breast Cancer Promotes Cardiac Dysfunction Through Deregulation of Cardiomyocyte Ca2+-Handling Protein Expression That is Not Reversed by Exercise Training.

Authors:  Tassia S R da Costa; Ursula Urias; Marcelo V Negrao; Camila P Jordão; Clévia S Passos; Igor L Gomes-Santos; Vera Maria C Salemi; Anamaria A Camargo; Patricia C Brum; Edilamar M Oliveira; Ludhmila A Hajjar; Roger Chammas; Roberto K Filho; Carlos E Negrao
Journal:  J Am Heart Assoc       Date:  2021-02-23       Impact factor: 5.501

8.  Excessive splenic volume is an unfavorable prognostic factor in patients with non-small cell lung cancer treated with chemoradiotherapy.

Authors:  Jianping Guo; Lei Wang; Xiaoyan Wang; Luo Li; Yajuan Lü; Congcong Wang; Chong Hao; Jiandong Zhang
Journal:  Medicine (Baltimore)       Date:  2020-12-04       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.